The Eikonal Non-Local approach models damage dependent non-local interactions by considering that interaction distances between material points are computed from solving an eikonal equation with an isotropic/anisotropic damage dependent metric Riemann function. In the finite element context, such a formulation exhibits good regularization properties and naturally allows one to model strain localization when non-local interactions vanish. In an isotropic damage mechanics framework, the damage variable tends to unity on a single integration point, and no damage diffusion occurs. In a one-dimensional context, evaluating the interaction distance between two points comes into computing an integral where the integrated function depends on the damage field between them. Desmorat et al. [9] performed the integration using a trapezoidal rule (under the assumption that the damage field is constant between adjacent integration points). Conversely, Jirásek and Desmorat [19] assumed that the damage field is linear between nearby integration points. Mainly motivated by improved integration accuracy, this method leads to a more gradual damaging process and makes it easier to follow the structural response when damage localizes. In this contribution, we show that despite these advantages, such a choice induces parasite damage diffusion issues, making the use of a standard trapezoidal rule more relevant. Moreover, once this choice is made, the structural response during damage localization can be conveniently described using a path-following method based on controlling the non-local strain variation of the localizing element instead of the local strain as in the works cited above.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.